Search…

    Saved articles

    You have not yet added any article to your bookmarks!

    Browse articles
    Select News Languages

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policies, and Terms of Service.

    Mounjaro sales double amid obesity drug boom

    1 hour ago

    4

    0

    Eli Lilly reported that worldwide sales of its obesity medication Mounjaro have doubled this year, reaching $18.6 billion in the first half, a 106% increase from 2025. The company also noted a 60% rise in Zepbound sales. The growth is driven by high demand in the US, despite lower average prices affecting revenues.
    Click here to Read more
    Prev Article
    Sales of Murphy’s Stout Double in a Year
    Next Article
    Derry City sacks manager Tiernan Lynch

    Related Health Updates:

    Comments (0)

      Leave a Comment